Summary by Futu AI
In July 5th, 2024, Innovent Bio submitted the latest monthly report of securities changes to Hong Kong Exchanges and Clearing Limited, reporting the changes in the company's shares up to June 30th, 2024. The report shows that Innovent Bio's statutory/registered share capital remains at 5,000,000,000 shares with a par value of 0.00001 US dollars per share, and the total share capital is 50,000 US dollars, which has not increased or decreased this month. The issued shares (excluding treasury shares) increased from 1,628,022,690 shares at the end of last month to 1,628,413,570 shares, an increase of 390,880 shares. The increase came mainly from the exercise of stock options, including initial public offering pre-share award plans and post-initial public offering employee shareholding plans. The total amount of funds received from exercising options this month was HKD 6,832,575.84. The report also confirms that the sale or transfer of all securities issued or treasury shares has been authorized by the board of directors and complies with all relevant listing rules and statutory requirements.
